OUR
MISSION We want to discover, develop
and successfully market innovative products to cure diseases, to ease suffering
and to enhance the quality of life. We
also want to provide a shareholder return that reflects outstanding performance
and to adequately reward those who invest ideas and work in our company. |
| CONTENTS | | NOVARTIS
GROUP BUSINESS REVIEW | | |
GROUP
REVIEW
| | 2 | FINANCIAL
HIGHLIGHTS | | 3 | NEWS | | 5 | LETTER
FROM DANIEL VASELLA | | |
OPERATIONAL
REVIEW | | 12 | BUSINESS
OVERVIEW: | | | PHARMACEUTICALS | | | SANDOZ | | | CONSUMER
HEALTH | | 22 | BUSINESS
STORIES | | |
CORPORATE
CITIZENSHIP | | 48 | INTRODUCTION | | 57 | COMMITMENT
TO PATIENTS | | 62 | COMMITMENT
TO OUR PEOPLE | | 67 | COMMITMENT
TO HEALTH, | | | SAFETY
AND ENVIRONMENT | | 74 | COMMITMENT
TO ETHICAL | | | BUSINESS
CONDUCT | | |
CORPORATE
GOVERNANCE | | 79 | COMMITMENT
TO CORPORATE | | | GOVERNANCE | | 98 | BOARD
OF DIRECTORS | | 104 | EXECUTIVE
COMMITTEE | | 108 | BUSINESS
UNIT HEADS | NOVARTIS
GROUP FINANCIAL REPORT |
111 |
CONTENTS | | 114 | OPERATING
& FINANCIAL REVIEW | | 134 | EQUITY
STRATEGY | | 136 | NOVARTIS
GROUP CONSOLIDATED FINANCIAL STATEMENTS | | 198 | NOVARTIS
AG FINANCIAL | | | STATEMENTS |
204 |
KEY
DATES 2006 | | 205 | CONTACT
ADDRESSES | | | |
|
